1. Home
  2. SPRU vs MIRA Comparison

SPRU vs MIRA Comparison

Compare SPRU & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spruce Power Holding Corporation

SPRU

Spruce Power Holding Corporation

HOLD

Current Price

$1.88

Market Cap

38.9M

ML Signal

HOLD

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$0.77

Market Cap

37.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRU
MIRA
Founded
2008
2020
Country
United States
United States
Employees
4
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
37.1M
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
SPRU
MIRA
Price
$1.88
$0.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
67.8K
87.4K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
62.30
N/A
EPS
0.02
N/A
Revenue
$23,194,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$100.00
N/A
Revenue Growth
48.68
N/A
52 Week Low
$1.43
$0.60
52 Week High
$6.75
$2.45

Technical Indicators

Market Signals
Indicator
SPRU
MIRA
Relative Strength Index (RSI) 42.79 47.13
Support Level $1.91 $0.60
Resistance Level $2.46 $0.83
Average True Range (ATR) 0.18 0.05
MACD 0.02 0.01
Stochastic Oscillator 38.06 48.38

Price Performance

Historical Comparison
SPRU
MIRA

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: